141 related articles for article (PubMed ID: 37059366)
1. Biomarkers Found in the Tumor Interstitial Fluid may Help Explain the Differential Behavior Among Keratinocyte Carcinomas.
Matas-Nadal C; Bech-Serra JJ; Gatius S; Gomez X; Ribes-Santolaria M; Guasch-Vallés M; Pedraza N; Casanova JM; de la Torre Gómez C; Garí E; Aguayo-Ortiz RS
Mol Cell Proteomics; 2023 Jun; 22(6):100547. PubMed ID: 37059366
[TBL] [Abstract][Full Text] [Related]
2. p63 expression in normal skin and usual cutaneous carcinomas.
Reis-Filho JS; Torio B; Albergaria A; Schmitt FC
J Cutan Pathol; 2002 Oct; 29(9):517-23. PubMed ID: 12358808
[TBL] [Abstract][Full Text] [Related]
3. The novel protein PTPIP51 is expressed in human keratinocyte carcinomas and their surrounding stroma.
Koch P; Stenzinger A; Viard M; Märker D; Mayser P; Nilles M; Schreiner D; Steger K; Wimmer M
J Cell Mol Med; 2008 Oct; 12(5B):2083-95. PubMed ID: 19012732
[TBL] [Abstract][Full Text] [Related]
4. Association of Human Papillomavirus Vaccine With the Development of Keratinocyte Carcinomas.
Nichols AJ; Allen AH; Shareef S; Badiavas EV; Kirsner RS; Ioannides T
JAMA Dermatol; 2017 Jun; 153(6):571-574. PubMed ID: 28196178
[TBL] [Abstract][Full Text] [Related]
5. Increased WD-repeat containing protein 1 in interstitial fluid from ovarian carcinomas shown by comparative proteomic analysis of malignant and healthy gynecological tissue.
Haslene-Hox H; Oveland E; Woie K; Salvesen HB; Wiig H; Tenstad O
Biochim Biophys Acta; 2013 Nov; 1834(11):2347-59. PubMed ID: 23707566
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronan, CD44 and versican in epidermal keratinocyte tumours.
Karvinen S; Kosma VM; Tammi MI; Tammi R
Br J Dermatol; 2003 Jan; 148(1):86-94. PubMed ID: 12534600
[TBL] [Abstract][Full Text] [Related]
7. Correlation of angiogenesis with other immunohistochemical markers in cutaneous basal and squamous cell carcinomas.
Ciortea CD; Jung I; Gurzu S; Kövecsi A; Turdean SG; Bara T
Rom J Morphol Embryol; 2015; 56(2 Suppl):665-70. PubMed ID: 26429157
[TBL] [Abstract][Full Text] [Related]
8. Maspin expression in normal skin and usual cutaneous carcinomas.
Reis-Filho JS; Torio B; Albergaria A; Schmitt FC
Virchows Arch; 2002 Dec; 441(6):551-8. PubMed ID: 12461611
[TBL] [Abstract][Full Text] [Related]
9. Expression of selectin ligands by cutaneous squamous cell carcinoma.
Groves RW; Allen MH; Ross EL; Ahsan G; Barker JN; MacDonald DM
Am J Pathol; 1993 Oct; 143(4):1220-5. PubMed ID: 7692735
[TBL] [Abstract][Full Text] [Related]
10. Proteomic analysis of non-small cell lung cancer tissue interstitial fluids.
Li S; Wang R; Zhang M; Wang L; Cheng S
World J Surg Oncol; 2013 Aug; 11():173. PubMed ID: 23914992
[TBL] [Abstract][Full Text] [Related]
11. FABP5 in keratinocyte carcinomas: expression, secretion, and its impact on tumor aggressiveness.
Matas-Nadal C; Gatius S; Ribes-Santolaria M; Guasch-Vallés M; Gomez Arbones X; Casanova JM; Aguayo-Ortiz RS; Garí E
Arch Dermatol Res; 2024 Jun; 316(7):342. PubMed ID: 38847933
[No Abstract] [Full Text] [Related]
12. Expression of CD40 and Fas ligand in Bowen's disease, squamous cell carcinoma and basal cell carcinoma.
Jang TJ
Yonsei Med J; 2002 Jun; 43(3):304-8. PubMed ID: 12089736
[TBL] [Abstract][Full Text] [Related]
13. Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery.
Celis JE; Gromov P; Cabezón T; Moreira JM; Ambartsumian N; Sandelin K; Rank F; Gromova I
Mol Cell Proteomics; 2004 Apr; 3(4):327-44. PubMed ID: 14754989
[TBL] [Abstract][Full Text] [Related]
14. P16INK4a Immunostaining but Lack of Human Papilloma Virus Type 16 in Cutaneous Squamous Cell Carcinoma and Basal Cell Carcinoma: a Report from West Iran.
Ramezani M; Abdali E; Khazaei S; Vaisi-Raygani A; Sadeghi M
Asian Pac J Cancer Prev; 2016; 17(3):1093-6. PubMed ID: 27039730
[TBL] [Abstract][Full Text] [Related]
15. Expression of EGF receptor, involucrin, and cytokeratins in basal cell carcinomas and squamous cell carcinomas of the skin.
Lavrijsen AP; Tieben LM; Ponec M; van der Schroeff JG; van Muijen GN
Arch Dermatol Res; 1989; 281(2):83-8. PubMed ID: 2476080
[TBL] [Abstract][Full Text] [Related]
16. Interstitial Fluid in Gynecologic Tumors and Its Possible Application in the Clinical Practice.
Ura B; Di Lorenzo G; Romano F; Monasta L; Mirenda G; Scrimin F; Ricci G
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30545144
[TBL] [Abstract][Full Text] [Related]
17. Metastasis suppressor proteins in cutaneous squamous cell carcinoma.
Bozdogan O; Vargel I; Cavusoglu T; Karabulut AA; Karahan G; Sayar N; Atasoy P; Yulug IG
Pathol Res Pract; 2016 Jul; 212(7):608-15. PubMed ID: 27215390
[TBL] [Abstract][Full Text] [Related]
18. Human keratinocyte carcinomas have distinct differences in their tumor-associated macrophages.
Jiang X; Wang M; Cyrus N; Yanez DA; Lacher RK; Rhebergen AM; Brokowski C; Galan A; Book S; Colegio OR
Heliyon; 2019 Aug; 5(8):e02273. PubMed ID: 31463392
[TBL] [Abstract][Full Text] [Related]
19. FOXM1 is a downstream target of Gli1 in basal cell carcinomas.
Teh MT; Wong ST; Neill GW; Ghali LR; Philpott MP; Quinn AG
Cancer Res; 2002 Aug; 62(16):4773-80. PubMed ID: 12183437
[TBL] [Abstract][Full Text] [Related]
20. Timing of subsequent new tumors in patients who present with basal cell carcinoma or cutaneous squamous cell carcinoma.
Wehner MR; Linos E; Parvataneni R; Stuart SE; Boscardin WJ; Chren MM
JAMA Dermatol; 2015 Apr; 151(4):382-8. PubMed ID: 25588079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
